Laboratory pipette with drop of liquid over glass test tubes in a science research lab

20 July - trading update

The AIM-listed international healthcare group has announced a trading update covering the six month period to 30 June which has revealed that trading has been strong with see-through revenues up by 24% on the same period in 2020 at £80.9m.  The Consumer Healthcare business performed strongly with revenues up by 30% to £56.8m, whilst growth in the Prescription Medicines business was somewhat lower at 12% as revenues here rose to £24.1m.  The group expects this strong performance to continue in the second half and full year results are expected to be . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.